Life Science News

RSS

View News A-Z »

Honeybees increase social distancing in response to a common parasite

Honeybees increase social distancing in response to a common parasite

Honeybees increase social distancing when their hive is under threat from a parasite, finds a new study led by an international team involving researchers at UCL and the University of Sassari, Italy.

30 Oct 2021

Researchers decipher when and why T cells become non-responsive to immunotherapy

Researchers decipher when and why T cells become non-responsive to immunotherapy

Non-small cell lung cancer is the most common type of lung cancer in humans. Some patients with NSCLC receive a therapy called immune checkpoint blockade (ICB) that helps kill cancer cells by reinvigorating a subset of immune cells called T cells, which are "exhausted" and have stopped working.

30 Oct 2021

Cancer cells exploit genetic and cellular processes to promote tumor growth

Cancer cells exploit genetic and cellular processes to promote tumor growth

Writing in EMBO reports, researchers at University of California San Diego School of Medicine and Moores Cancer Center at UC San Diego Health describe how a pair of fundamental genetic and cellular processes are exploited by cancer cells to promote tumor survival and growth.

29 Oct 2021

Atomic-level imaging of artificial proteins

Atomic-level imaging of artificial proteins

Scientists have created thin, paper-like crystalline sheets using a synthetic, protein-like molecule called a polypeptoid. These nanosheets are only one molecule thick, with the molecules arranged in very specific ways.

29 Oct 2021

Drug-like molecule can counteract the effects of mutated epigenetic regulators that drive cancers

Drug-like molecule can counteract the effects of mutated epigenetic regulators that drive cancers

A decade ago, genome sequencing revealed a big surprise: about 50 percent of human cancers are linked to mutations in what are known as epigenetic regulators, which control the activity of genes.

29 Oct 2021

Researchers develop eToeholds for safe, effective RNA and cellular therapies

Researchers develop eToeholds for safe, effective RNA and cellular therapies

RNAs are best known as the molecules that translate information encoded in genes into proteins with their myriad of activities.

29 Oct 2021

New approach to control the hierarchical assembly of protein pathways with DNA

New approach to control the hierarchical assembly of protein pathways with DNA

Northwestern investigators have identified a novel approach to control the hierarchical assembly of protein pathways with DNA, according to a study published the Proceedings of the National Academy of Sciences.

29 Oct 2021

Beckman Coulter Life Sciences expands customer access to experts, resources with 3D Digital Campus

Beckman Coulter Life Sciences expands customer access to experts, resources with 3D Digital Campus

Building on a relentless commitment to customer service and innovation, Beckman Coulter Life Sciences debuts a powerful new interactive customer resource with the launch of its Digital Campus.

From Beckman Coulter Life Sciences - Flow Cytometry 29 Oct 2021

Scientists uncover key genetic networks governing human embryonic stem cell behavior

Scientists uncover key genetic networks governing human embryonic stem cell behavior

At the earliest stages of human embryonic development, a small collection of cells known as human embryonic stem cells (hESCs) orchestrates growth and differentiation, eventually giving rise to highly specialized human tissues.

28 Oct 2021

Mitochondrial proteins last much longer than expected, finds study

Mitochondrial proteins last much longer than expected, finds study

Mitochondria are known as the powerhouses of the cell, generating the energy that's needed to fuel the functions that our cells carry out.

28 Oct 2021

Penn's newly created split-engineered base editors show potential for research, therapeutics

Penn's newly created split-engineered base editors show potential for research, therapeutics

Targeted mutations to the genome can now be introduced by splitting specific mutator enzymes and then triggering them to reconstitute, according to research from the Perelman School of Medicine at the University of Pennsylvania.

28 Oct 2021

Novel ribosome-targeting antibiotic overcomes bacterial multidrug resistance

Novel ribosome-targeting antibiotic overcomes bacterial multidrug resistance

A new study published in Nature reports on a new antibiotic that binds to the ribosome of bacterial cells and stops drug-resistant pathogens from making mice sick.

28 Oct 2021

New method reveals changes in protein structure more efficiently and accurately than before

New method reveals changes in protein structure more efficiently and accurately than before

Important processes take place among the subunits of the molecules that make up our cells. Defects in these processes or distortions in the subunits can lead to serious diseases.

28 Oct 2021

A new approach to selectively turn on gene therapies in target cells

A new approach to selectively turn on gene therapies in target cells

Researchers at MIT and Harvard University have designed a way to selectively turn on gene therapies in target cells, including human cells.

28 Oct 2021

New insight into the tremendously complex "genetic dance"

New insight into the tremendously complex "genetic dance"

The rapid scientific advancements that followed the mapping of the human genome have revealed just how staggeringly complex the world of genetics is.

28 Oct 2021

Researchers discover genetic risk variants involved in osteoarthritis

Researchers discover genetic risk variants involved in osteoarthritis

Osteoarthritis is the leading cause of pain and disability worldwide. There is no cure, only pain relief. Patients' joints become inflamed, and they feel creaky and stiff in the morning.

28 Oct 2021

Immune cell patterns can help predict if kidney cancer patients will respond to immunotherapy

Immune cell patterns can help predict if kidney cancer patients will respond to immunotherapy

Researchers at the Francis Crick Institute, The Royal Marsden NHS Foundation Trust and UCL have found immune cell patterns within tumors that can help predict if patients with kidney cancer will respond to immunotherapy.

28 Oct 2021

Sphere Fluidics closes a $40 million funding round led by Sofinnova Partners and Redmile Group

Sphere Fluidics closes a $40 million funding round led by Sofinnova Partners and Redmile Group

Sphere Fluidics announced today that it has closed a $40 million (circa £30 million) investment round.

From Sphere Bio 28 Oct 2021

OSU research shines light on the way malignant cancer cells change shape

OSU research shines light on the way malignant cancer cells change shape

Oregon State University research has shed new light on the way malignant cells change their shape and migration techniques to invade different types of tissue.

28 Oct 2021

New system created for targeted delivery of anti-cancer drugs

New system created for targeted delivery of anti-cancer drugs

RUDN University and Shahid Beheshti University (SBU) chemist together with colleagues from Iran created a system for targeted delivery of anti-cancer drugs.

27 Oct 2021

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.